2m 2m 2m 2m 2m 2m 2m
Compugen (CGEN)
NASDAQ
$2.18-$0.02 (-0.68%)
Price as of Jun 03, 2026 7:26 PM EDT- $208.5MMarket Cap
- 28.07%1-Year Change
- BiotechnologyIndustry
Compugen (CGEN)
$2.18-$0.02 (-0.68%)
Annual
Quarterly
12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 72.8M +161.14% | 27.9M -16.72% | 33.5M +346.12% | 7.5M +25.00% | |
Cost of Revenue | 9.3M +16.66% | 7.9M +295.71% | 2.0M +105.54% | 975,000 +43.38% | |
Gross Profit | 63.5M +218.62% | 19.9M -36.63% | 31.5M +382.07% | 6.5M +22.65% | |
Sales and Marketing Expense | 539,000 -6.42% | 576,000 +136.07% | 244,000 -73.82% | 932,000 +10.69% | |
Research and Development Expense | -22.8M -8.27% | -24.8M -28.03% | -34.5M +12.48% | -30.6M +6.81% | |
Depreciation and Amortization Expense | 475,000 -2.26% | 486,000 +2.10% | 476,000 -1.24% | 482,000 +4.56% | |
Total Operating Expenses | 32.2M -7.58% | 34.8M -21.65% | 44.4M +6.08% | 41.9M +3.73% | |
Operating Profit | 35.3M +348.35% | -14.2M -24.12% | -18.8M -44.34% | -33.7M -1.49% | |
Interest Income | 3.9M +11.92% | 3.5M +17.87% | 3.0M +105.98% | 1.4M +60.74% | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 3.9M +11.92% | 3.5M +17.87% | 3.0M +105.98% | 1.4M +60.74% | |
Total Nonoperating Income and Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Income before Taxes | 35.3M +348.35% | -14.2M -24.12% | -18.8M -44.34% | -33.7M -1.49% | |
Income Taxes | 54,000 -98.81% | 4.5M -49.59% | 9.0M +15,365.52% | 58,000 N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | 35.3M +348.35% | -14.2M -24.12% | -18.8M -44.34% | -33.7M -1.49% | |
Net Income from Continuing Operations Applicable to Common | 35.3M +348.35% | -14.2M -24.12% | -18.8M -44.34% | -33.7M -1.49% | |
Basic EPS and Net Income | 0.38 +337.50% | -0.16 -23.81% | -0.21 -46.15% | -0.39 -4.88% | |
Diluted EPS and Net Income | 0.38 +337.50% | -0.16 -23.81% | -0.21 -46.15% | -0.39 -4.88% | |
Basic Weighted Average Shares | 93.4M +4.35% | 89.5M +2.16% | 87.6M +1.25% | 86.6M +2.79% | |
Diluted Weighted Average Shares | 93.8M +4.79% | 89.5M +2.16% | 87.6M +1.25% | 86.6M +2.79% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 90.6M +396.99% | 18.2M +31.24% | 13.9M +25.60% | 11.1M +41.76% | |
Short-Term Investments | 9.3M -60.71% | 23.6M +101.23% | 11.7M N/A | N/A N/A | |
Cash and Cash Equivalents and Short-Term Investments | 99.9M +138.62% | 41.9M +63.30% | 25.6M +131.78% | 11.1M +41.76% | |
Total Current Assets | 148.0M +39.65% | 106.0M -7.49% | 114.6M +33.04% | 86.1M -30.11% | |
Accumulated Depreciation | 685,000 -88.08% | 5.7M +7.32% | 5.4M -14.03% | 6.2M +6.62% | |
Property and Plant and Equipment and Net | 681,000 -20.07% | 852,000 -29.93% | 1.2M -20.63% | 1.5M -7.60% | |
Total Long-Term Assets | 8.5M -5.00% | 9.0M +33.21% | 6.8M -16.10% | 8.1M -9.95% | |
Total Assets | 156.6M +36.15% | 115.0M -5.22% | 121.3M +28.84% | 94.2M -28.74% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 22.6M +11.95% | 20.2M -23.25% | 26.3M +120.37% | 11.9M -30.28% | |
Total Long-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Long-Term Liabilities | 31.3M -21.67% | 39.9M +35.28% | 29.5M +544.72% | 4.6M -45.34% | |
Total Liabilities | 25.0M +10.54% | 22.6M -16.16% | 27.0M +103.95% | 13.2M -30.65% | |
Retained Earnings | -453.4M -7.23% | -488.8M +3.00% | -474.5M +4.11% | -455.8M +7.98% | |
Total Stockholders Equity | 102.7M +87.08% | 54.9M -16.24% | 65.6M -15.60% | 77.7M -27.19% | |
Total Shares Outstanding | 94.6M +5.60% | 89.5M +0.34% | 89.2M +3.02% | 86.6M +0.22% | |
Cash Flow | |||||
Cash from Operating Activities | 31.6M -36.23% | 49.6M +238.23% | -35.9M +4.00% | -34.5M +51.67% | |
Capital Expenditures | 306,000 +159.32% | 118,000 -31.40% | 172,000 -63.94% | 477,000 +63.36% | |
Cash from Investing Activities | 30.0M +164.85% | -46.3M -230.25% | 35.5M -4.18% | 37.1M +460.16% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 10.6M +1,814.08% | 554,000 -82.02% | 3.1M +772.80% | 353,000 -97.90% | |
Financials Ratio | |||||
Gross Margin | 87.29% +22.01% | 71.54% -23.90% | 94.01% +8.06% | 87.00% -1.88% | |
Operating Margin | 48.57% +195.10% | -51.07% -8.88% | -56.05% -87.52% | -449.25% -21.19% | |
Return on Assets | 26.03% +316.13% | -12.04% -30.80% | -17.40% -41.54% | -29.77% +17.72% | |
Return on Equity | 44.84% +289.79% | -23.63% -9.78% | -26.19% -28.36% | -36.55% +21.01% | |
Revenue Growth | 161.14% +1,063.64% | -16.72% -104.83% | 346.12% +1,284.48% | 25.00% -87.50% | |
Current Ratio | 6.56 +24.74% | 5.26 +20.53% | 4.36 -39.63% | 7.23 +0.25% | |
Cash Ratio | 4.01 +343.93% | 0.90 +70.99% | 0.53 -43.00% | 0.93 +103.33% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow